PROCEPT BioRobotics Corporation PRCT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 64%+1.3pp | 63.7%+2.6pp | 64.5%+7.2pp | 64.2%+9.5pp | 62.7%+9.2pp | |
| Operating margin | -33.9%+4.8pp | -33.7%+9.3pp | -30.9%+22.4pp | -33.4%+28.7pp | -38.7%+30.7pp | |
| Net margin | -31.8%+4.4pp | -31%+9.7pp | -28.2%+21.9pp | -30.6%+28.1pp | -36.2%+29.9pp | |
| EBITDA margin | -31.8%+4.7pp | -31.6%+9.1pp | -28.8%+21.9pp | -31.2%+28.1pp | -36.5%+30.2pp | |
| Free cash flow margin | -25%+10.4pp | -18.9%+27.2pp | -26.6%+25.2pp | -32.5%+29.4pp | -35.4%+45.3pp | |
| Returns | ||||||
| Return on equity | -27.8%-0.2pp | -24.9%+1.9pp | -27.2%+9.8pp | -26.4%+24.5pp | -27.6%+19.7pp | |
| Return on assets | -20.4%-0.4pp | -18.3%+1.1pp | -19.1%+6.1pp | -19%+13.1pp | -20%+11.0pp | |
| Return on invested capital | -38.1%+31.9pp | -35.9%+42.8pp | -65.2%+36.1pp | -66.7%+43.6pp | -70.1%+47.1pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.6×+0.1× | 0.7×+0.2× | 0.6×+0.1× | 0.6×+0.1× | |
| Inventory turnover | 1.7×-0.1× | 1.8×-0.1× | 1.8×0.0× | 1.8×-0.1× | 1.8×0.0× | |
| Liquidity | ||||||
| Current ratio | 6.7×-2.2× | 6.8×-2.2× | 8.4×+2.4× | 9.2×+1.7× | 8.9×+0.4× | |
| Quick ratio | 5.5×-2.2× | 5.8×-2.2× | 7.2×+2.1× | 7.9×+1.4× | 7.7×+0.3× | |
| Cash ratio | 0.2×-5.9× | 0.2×-6.2× | 5.5×+1.8× | 6.1×+1.1× | 6.1×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×-0.1× | 0.2×-0.1× | 0.2×-0.1× | |
| Debt-to-assets | 0.2×0.0× | 0.2×0.0× | 0.2×-0.1× | 0.2×-0.1× | 0.2×0.0× | |
| Interest coverage | -30.9×-6.9× | -29×-5.9× | -25.3×-0.8× | -23.6×+2.3× | -24×+2.1× | |
| Per Share | ||||||
| Book value per share | $6.15-13.2% | $6.59-14.6% | $6.82+47.1% | $6.96+42.7% | $7.09+36.9% | |
| Valuation | ||||||
| Market capitalization | $1.19B-24.8% | —— | —— | —— | —— | |
| Enterprise value | $1.25B— | —— | —— | —— | —— | |
| Price / sales | 3.7×— | —— | —— | —— | —— | |
| Price / book | 3.4×— | —— | —— | —— | —— | |
| EV / sales | 3.9×— | —— | —— | —— | —— | |
| Free cash flow yield | -6.8%— | —— | —— | —— | —— | |
| Earnings yield | -8.6%— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are PROCEPT BioRobotics Corporation's profit margins?
- PROCEPT BioRobotics Corporation (PRCT) runs a 64.0% gross margin and a -33.9% operating margin, with a -31.8% net margin.
- Where do PROCEPT BioRobotics Corporation's ratios come from?
- Every ratio is computed from PROCEPT BioRobotics Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
